In HCC and CRC, METTL14 inhibits the occurrence of tumors by promoting the synthesis of tumor-suppressor miRNAs, whereas in breast cancer, METTL14 promotes the occurrence and development of tumors by enhancing the synthesis of tumor-promoting miRNAs. The gene discussed is METTL14; the disease is neoplasm.